Viewing Study NCT06100263



Ignite Creation Date: 2024-05-06 @ 7:42 PM
Last Modification Date: 2024-10-26 @ 3:11 PM
Study NCT ID: NCT06100263
Status: RECRUITING
Last Update Posted: 2024-06-04
First Post: 2023-10-20

Brief Title: Breast Cancer Resiliency Through Exercise Program B-REP
Sponsor: University of Michigan Rogel Cancer Center
Organization: University of Michigan Rogel Cancer Center

Study Overview

Official Title: Breast Cancer Resiliency Through Exercise Program B-REP Pilot Study
Status: RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: B-REP
Brief Summary: The study will use a cross-sectional study design with a follow-up 2-arm randomized controlled trial with that has assessments at baseline post-intervention ie Week 12 and 3-months post-intervention ie Week 24 The 2 arms are the 12-week intervention and a health education control among 60 Black breast cancer survivors
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
HUM00244376 OTHER University of Michigan None